2019/09/13
(寄稿)
Renewed Interest in Long-Acting Injectable and Implantable Drug Products
White Papers of Drug Delivery – Part 2/3
Christopher A. Rhodes (Ph.D), President & CEO of DDE Labs, Inc.
13 September 2019
Drug Delivery Technologies have been evolving with the development of pharmaceutics and biologics.
With these 3 articles, Dr. Christopher Rhodes, CEO of DDE Labs, describes the development and the frontline of Drug Delivery.
This is Part 2 of a Series of 3 segments.
(Table of content)
Part 1
- The Hope for Oral Delivery of Biologics
Part 2
- Renewed Interest in Long-Acting Injectable and Implantable Drug Products
Part 3
- The Challenges of Complex Generics
Keywords for the article: Drug Delivery, Oral Delivery, Injectable, Implantable, Long-acting systems,
Renewed Interest in Long-Acting Injectable and Implantable Drug Products
The pharmaceutical industry is witnessing a renewed interest in the last 10 years (2010 to 2019) in pharmaceutical products that are designed as long-acting injectables or as implantable systems.
Christopher A. Rhodes (Ph.D), President & CEO of DDE Labs, Inc.
13 September 2019
Drug Delivery Technologies have been evolving with the development of pharmaceutics and biologics.
With these 3 articles, Dr. Christopher Rhodes, CEO of DDE Labs, describes the development and the frontline of Drug Delivery.
This is Part 2 of a Series of 3 segments.
(Table of content)
Part 1
- The Hope for Oral Delivery of Biologics
Part 2
- Renewed Interest in Long-Acting Injectable and Implantable Drug Products
Part 3
- The Challenges of Complex Generics
Keywords for the article: Drug Delivery, Oral Delivery, Injectable, Implantable, Long-acting systems,
Renewed Interest in Long-Acting Injectable and Implantable Drug Products
The pharmaceutical industry is witnessing a renewed interest in the last 10 years (2010 to 2019) in pharmaceutical products that are designed as long-acting injectables or as implantable systems.
(Continued..)
連載記事
